Pharmaceutical Investing Vitality Biopharma Achieves Cannabinoid Pharmaceutical Biosynthesis Breakthrough
BioQ Pharma Expands U.S. License and Supply Agreement to Commercialize Third Ready-to-Use Infusion Product
Pharmaceutical Investing Turing Pharmaceuticals Backtracks After 5,000-percent Price Increase for Daraprim